Tenpoint Therapeutics, a London and Seattle-based biotechnology company developing vision rejuvenation treatments for the aging eye, has raised $235m through a Series B stock financing and a credit facility, with the Series B led by Janus Henderson, EQT Nexus, Hillhouse and British Business Bank.

Other participants in the Series B included existing investors EQT Life Sciences, Sofinnova Partners and F-Prime; Tenpoint also entered into a $150m non-dilutive senior secured term loan facility with Hercules Capital.

Led by CEO Henric Bjarke and Chairman Dr. David Guyer, Tenpoint Therapeutics is focused on bringing innovation to the aging eye through the development and commercialization of treatments for conditions such as presbyopia. Its lead product, YUVEZZI™ (carbachol and brimonidine tartrate ophthalmic solution), was recently approved by the U.S. FDA as the only dual-agent, once-daily eye drop for presbyopia, a condition affecting nearly 2 billion people globally.

The company intends to use the funds to strengthen its balance sheet and accelerate commercialization of YUVEZZI following U.S. FDA approval.

Recare, a Berlin-based provider of technology solutions for hospitals and care providers, has closed a growth financing round of up to €37 million, including a €7 million option, led by DNV.

The round included participation from CIBC Innovation Banking and other investors, and makes DNV the largest shareholder in Recare.

Founded in 2017 by Maximilian Greschke and Charles Cote, Recare is focused on reshaping discharge management and facilitating effective patient transfer from hospitals to care providers. The HealthTech company aims to improve hospital operations and care coordination through its AI-driven workflow technology.

Recare’s AI agent is designed to automate administrative tasks and coordinate clinical and administrative workflows across departments by connecting existing hospital IT systems. It automates documentation and routine tasks such as medical letters and handover protocols, and extracts and structures data from PDFs, scans and free text into interoperable formats to break down data silos and support end-to-end workflow continuity. The company says its network connects approximately two-thirds of all German hospitals, more than 650 rehabilitation clinics and 26,000 nursing and homecare providers.

The fresh capital will be used to fast-track the introduction of a new AI agent to hospitals and care facilities and to expand Recare’s international business, accelerating the roll-out of its platform across Germany and abroad.

“Hospitals are under enormous operational pressure, as healthcare professionals spend increasing time on administrative tasks—leaving less capacity for what matters most: caring for patients. Recare’s AI agent platform relieves a large part of this administrative burden by leveraging unstructured data to rapidly orchestrate workflows. The new investment into our business will accelerate the roll-out of our AI agent across Germany and abroad, helping healthcare providers to transform their workforce capacity.”

Munich-based Twogee Biotech, a biotechnology startup developing customised enzyme solutions for the industrial conversion of biomass into sustainable raw materials, has completed a €2.2 million seed financing round led by High‑Tech Gründerfonds.

The round also included investments from Bayern Kapital and strategic partners AgriFoodTech Venture Alliance and Heinz Entsorgung.

Founded in 2024 by Frank Wallrapp and Helge Jochens in Munich, Twogee Biotech supports industrial partners in converting low-value biomass residues and by-products into second-generation raw materials, with a focus on sugars for bio- and synthetic biology applications.

The company’s approach is built on a predictive development platform that integrates enzyme screening, strain engineering and fermentation to enable more efficient biomass utilisation, shorten development timelines and reduce scale-up risk.

The company plans to use the newly raised capital to further develop its technology and advance commercialisation; initial MVPs and paid pilot projects with industrial partners have already been completed. Twogee intends to pursue a licensing model enabling local enzyme production at customer sites to reduce costs and emissions while supporting decentralised, circular value chains.

Frank Wallrapp, CEO of Twogee Biotech, said that many industrial residual streams contain untapped economic potential and that the company supports partners in accessing this value through solutions designed for straightforward integration and clear commercial benefits.

Stilla (stilla.ai), a Stockholm-based developer of collaborative intelligence that maintains shared context across organisational tools to coordinate actions between humans and AI agents, has emerged from stealth with 5 million dollars in pre-seed funding led by General Catalyst.

The round included participation from a group of angel investors.

The company was founded by Siavash Ghorbani and Kaj Drobin in Stockholm; the founders previously contributed to the development of Shop and Shop Pay at Shopify.

Stilla provides an infrastructure layer that connects core workplace tools such as Slack, Linear, GitHub and Notion to maintain a continuously updated understanding of what teams are working on, why decisions are made and how work progresses. By distributing relevant context across teams and AI systems, the platform aims to support coordinated execution at scale and is already in use at companies including Spotify, Ramp, Lovable and Legora.

The company plans to use the capital to further build its core infrastructure, enable better coordination between human teams and AI agents, continue integrations with existing workplace systems and expand the platform’s capabilities based on early adoption by product teams.

Berlin-based GeneralMind, an AI startup building its own “System of Action” designed to be an operational AI layer on top of ERP systems, has closed a €10.2 million equity financing led by Lakestar, Leo Capital, Lucid Capital, Heliad and BOOOM.

The round was completed less than six months after the company began operating and included angel investors Alexander Kudlich, Jens Urbaniak and Samir Sood.

Founded in 2025 by the team that built the German unicorn Razor Group, GeneralMind is led by founder and CEO Tushar Ahluwalia and is headquartered in Berlin, with a second site in Bangalore, India.

GeneralMind is building an autonomous AI “System of Action” that takes over repetitive white-collar work and unstructured email back-and-forth along the supply chain. Its AI Autopilot autonomously executes recurring workflows end-to-end across email, Excel and enterprise systems, capturing incoming tasks, analysing and executing them while tracking handovers, deadlines and compliance. The product is aimed at mid-sized and large enterprises across industry, commerce and logistics, and the company says its technology is used by firms listed on NASDAQ, MDAX and SDAX.

Kraken, a software firm spun out of Octopus Energy that provides software to utilities companies, has raised a £25m investment from the British Business Bank as part of a $1bn share sale that values Kraken at $8.56bn.

The bank, which is a major limited partner in UK venture capital funds, also pledged to invest £50m apiece into two UK deep tech funds: Epidarex Capital, based in Edinburgh, and IQ Capital, based in London.

The transaction is the British Business Bank’s largest ever direct investment into a private company. Octopus Energy announced in December that it would spin Kraken out into its own entity; Kraken supplies software to utilities companies.

The investment follows reforms to the bank’s mandate allowing it to take higher‑risk stakes in businesses operating in areas prioritised by the UK’s Modern Industrial Strategy, including advanced manufacturing and clean energy. Business secretary Peter Kyle also used the announcement at Kraken’s headquarters to outline measures to improve conditions for UK businesses, including plans to allow virtual AGMs, streamline corporate reporting and consult on simplifying competition investigations.

“We are placing big bets on the industries where Britain can win, backing our innovators with real firepower, and cutting the red tape that holds them back,” said UK business secretary Peter Kyle.

Pennylane, the Paris-based accounting production and financial management platform for accounting firms and their clients, has raised €175 million in a funding round led by TCV.

The round included participation from Blackstone through funds managed by Blackstone Growth, alongside existing shareholders Sequoia Capital, DST Global, CapitalG and Meritech Capital.

Founded in 2020 and led by co-founder and CEO Arthur Waller, Pennylane provides a single platform for financial and accounting data that helps entrepreneurs manage invoicing and payments, pay suppliers and control expenses, and pilot cash and profitability, while enabling accountants to handle bookkeeping and tax filings.

The company supports over 6,000 firms and 800,000 client companies and employs around 1,000 people. Since 2024 Pennylane has been registered as an Authorised Platform and operates an electronic invoicing solution; in April 2025 it raised an additional €75 million co-led by Sequoia Capital, CapitalG and Meritech, and in November 2025 it entered the German market.

Pennylane said the new capital will be deployed to intensify R&D — including building generative AI tools such as an analysis-assistant co-pilot for accountants — to localise products for German regulatory requirements, to strengthen infrastructure and prepare users for the transition to electronic invoicing from 2026 as an authorised platform, and to enrich its payments and cash management offering; the fundraising also secures long-term resources to anticipate European market consolidation as the company approaches profitability.

Tulip, a Somerville, MA-based provider of a frontline operations platform, raised $120 million in Series D funding led by Mitsubishi Electric Corporation.

Tulip provides a Frontline Operations platform that delivers an AI-native, no-code solution with edge capabilities to connect the people, machines, devices and systems used in operations. The company supports manufacturers including AstraZeneca, Richemont, Stanley Black & Decker and DMG Mori across industries such as general manufacturing, pharmaceutical and biotechnology, labs and warehousing, and maintains offices in Munich, Budapest, Singapore, Tel Aviv and now Tokyo.

Natan Linder, CEO of Tulip, said the partnership is grounded in a common vision: people remain the most critical element of manufacturing. Rather than replacing workers, the aim is to empower them with new capabilities through practical AI. He emphasized that platforms should be designed with operators and engineers as the primary users, adding that this collaboration will support the development of modern, trust-based operations focused on continuous improvement.

The company intends to use the funds to expand operations and its development efforts.

TaleMonster Games, an Istanbul-based mobile game studio behind the puzzle title Match Valley, has raised $30 million in a Series A funding round led by Arcadia Gaming Partners and Andreessen Horowitz.

Other participants in the round include Point72 Ventures and General Catalyst, and the company also drew support from Andreessen Horowitz’s Speedrun arm, where investor Josh Lu became involved after seeing the team’s prototype.

Talemonster was founded by CEO Irem Sumer alongside four cofounders who left Peak Games to build the company in Istanbul. The team developed Match Valley over roughly two years, launching the title in August after a seed round the prior February that raised $7 million and supported a stable build with 200 levels.

Match Valley is a mobile puzzle game that combines match-three mechanics with tower-defense elements and a roster of hero characters with unique abilities. The game monetizes through in-app purchases; early engagement metrics cited by the company show an average playtime of one and a half hours per player and about two and a half hours on the first day, and the team expanded to a 32-person remote staff to support engineering, art, product, level design, and marketing.

The $30 million Series A will be used to grow Match Valley — including building additional levels to address rapid content consumption — and to develop a new game the company plans to release this year, while maintaining a lean team structure.

“I wasn’t planning to fundraise in September because I believed it was a bit too early for us. But the metrics were good, and there was a lot of strategic interest in our company,” said Sumer.